We are live on
!
Find out more
SCA
Sassicaia Capital Advisers Portfolio holdings
AUM
$88.8M
1-Year Est. Return
146.47%
This Fund
S&P 500
This Quarter
Est. Return
+1.56%
1 Year Est. Return
+146.47%
3 Year Est. Return
+1,930.21%
5 Year Est. Return
+4,169.37%
10 Year Est. Return
–
AUM
$27.6M
AUM Growth
+$23.5M
(+568%)
Cap. Flow
+$24.6M
Cap. Flow
% of AUM
89.27%
Top 10 Holdings %
Top 10 Hldgs %
79.78%
Holding
33
New
26
Increased
–
Reduced
1
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$12.4M |
| 2 |
NVIDIA
NVDA
|
+$1.72M |
| 3 |
Carvana
CVNA
|
+$1.6M |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.29M |
| 5 |
TSMC
TSM
|
+$1.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.95M |
| 2 |
Moderna
MRNA
|
+$603K |
| 3 |
CYBR
CyberArk
CYBR
|
+$333K |
| 4 |
X
US Steel
X
|
+$272K |
| 5 |
NRX Pharmaceuticals
NRXP
|
+$33K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 64.16% |
| 2 | Consumer Discretionary | 12.38% |
| 3 | Communication Services | 6.29% |
| 4 | Consumer Staples | 4.3% |
| 5 | Financials | 1.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICCT
26
DELISTED
iCoreConnect
ICCT
| $31.4K | 0.11% |
+14,000
| New | +$23.4K |
|
|
LYRA
27
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $1.26K | ﹤0.01% |
+200
| New | +$1.87K |
|
28
Aethlon Medical
AEMD
$1.67M
| – | – |
-90
| Closed | -$31K |
|
|
CYBR
29
DELISTED
CyberArk
CYBR
| – | – |
-1,000
| Closed | -$333K |
|
|
30
Moderna
MRNA
$24.2B
| – | – |
-14,500
| Closed | -$603K |
|
|
31
NRX Pharmaceuticals
NRXP
$146M
| – | – |
-15,000
| Closed | -$33K |
|
|
X
32
DELISTED
US Steel
X
| – | – |
-8,000
| Closed | -$272K |
|
33
Haoxi Health Technology Ltd
HAO
$1.21M
| – | – |
-3
| Closed | -$1.5K |
|
Similar funds
HI
VA
MPEM
RFL
PBCM
PM
BCP
CVM
Sassicaia Capital Advisers's Q1 2025 Portfolio in Review
As of Q1 2025, Sassicaia Capital Advisers held 33 positions worth $27.6M, up 568% from $4.14M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Sassicaia Capital Advisers deployed $24.6M of net new capital in Q1 2025, opening 26 new positions. Its largest new stake was Apple: 53,600 shares worth $11.9M.
By sector, the portfolio is most concentrated in Technology at 64% of assets, up from 8.1% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.95M trimmed.
- Sassicaia Capital Advisers's largest Q1 2025 buy was Apple: 53,600 shares worth $11.9M.
- Sassicaia Capital Advisers's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.95M.
- Sassicaia Capital Advisers fully exited Moderna in Q1 2025, selling an estimated $603K.
- Sassicaia Capital Advisers's ten largest holdings make up 80% of its $27.6M portfolio in Q1 2025.
- Sassicaia Capital Advisers opened 26 new positions and closed 6 in Q1 2025.
- Sassicaia Capital Advisers's portfolio value rose 568% quarter-over-quarter to $27.6M.
Based on Sassicaia Capital Advisers's 13F filing for Q1 2025, filed 15 May 2025.